Product Code: CHAU
TABLE OF CONTENTS
List Of Contents And Tables
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2020-2021
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
ANALGESICS IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Strong demand for analgesics during pandemic continues to drive value sales in 2021
GSK Consumer Healthcare retains overall leadership of analgesics
Reckitt Benckiser remains strongest competitor to GSK Consumer Healthcare in 2021
PROSPECTS AND OPPORTUNITIES
Increase in elderly population suffering from chronic illnesses to support growth of analgesics over the forecast period
Solid demand for trusted analgesics in terms of efficacy
New entry intends to disrupt the competitive landscape
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Cold, cough and allergy (hay fever) remedies experiences polarising trends in 2021
Australians remain prepared to tackle various health concerns
Despite challenging market conditions, Johnson & Johnson retains leadership of cough, cold and allergy (hay fever) remedies in 2021
PROSPECTS AND OPPORTUNITIES
Technological breakthrough with influenza vaccine likely to impact demand for cough, cold and allergy (hay fever) remedies
Segmentation as a strategy to add value
Climate to maintain demand for antihistamines/allergy remedies (systemic) over the forecast period
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Ageing demographic contributes to demand for digestive remedies
Greater alcohol intake as a result of the pandemic supports demand for antacids
Johnson & Johnson retains leadership of digestive remedies with wide product portfolio
PROSPECTS AND OPPORTUNITIES
Positive performance predicted for digestive remedies to be supported by prevailing trends including ageing population
Threat of substitution from probiotic supplements over the forecast period as Australians look to prevention over cure
Slower rate of decline for H2 blockers but Australians now rely on alternatives
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Demand for dermatologicals starts to stabilise following 2020's stockpiling
Atopic dermatitis and seborrheic dermatitis sufferers benefit from switch of mometasone furoate
Dermatologicals remains highly fragmented competitive landscape in Australia
PROSPECTS AND OPPORTUNITIES
Negative side effects of hand sanitisers may trigger new product development
Ongoing impact of COVID-19 on consumers' psychological wellbeing will drive demand for hair loss treatments
Ageing population another contributing factor to growth of dermatologicals
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
COVID-19 health trends continue to encourage Australians to quit smoking
Australians adopt different methods to support their attempts to quit, including digital apps
Nicorette maintains its dominance due to wide availability and strong reputation
PROSPECTS AND OPPORTUNITIES
Technological advances within NRT smoking cessation aids and quitting apps set to drive new product developments over the forecast period
Long-term downward trend in tobacco smoking to slow growth of NRT smoking cessations aids over the forecast period
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2016-2021
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Positive growth by sleep aids supported by melatonin switch
Mental health issues to strengthen reliance on sleep aids post-pandemic
Dozile retains convincing leadership, but new entry melatonin-based Circadin gains ground
PROSPECTS AND OPPORTUNITIES
Solid demand for sleep aids over the forecast period
Herbal/traditional products expected to contribute to continued growth
Polarising trends for growth of sleep aids over the forecast period
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2016-2021
Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Novelty of being able to leave the home boosts outdoor activities, supporting demand for allergy care
Work from home arrangements continue in Australia, positively impacting standard eye care
Eye care remains consolidated competitive landscape
PROSPECT AND OPPORTUNITIES
Remote working trend to ease over forecast period, hampering growth of standard eye care
Rapidly evolving developments within vision science have potential to hamper longer-term growth of standard eye care
Stronger performance for allergy eye care due to the longer allergy season and rising allergen levels
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2016-2021
Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Return to low undynamic growth rates for wound care in 2021 as Australians use accumulated stock
Mature category needs innovation to drive value
Elastoplast and Band-Aid remain popular trusted wound care brands
PROSPECTS AND OPPORTUNITIES
Ageing population to stimulate demand for wound care over forecast period
Rising number of diabetes patients in Australia contributing factor to demand
Offering innovative products with natural positioning could offer stronger value growth potential
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2016-2021
Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN AUSTRALIA
HEADLINES
PROSPECTS
Challenging environment for companies competing within vitamins
COVID-19 challenges leading position of health and beauty specialist retailers as preferred channel of distribution for vitamins
New products and the rise of "purpose-driven" businesses
PROSPECTS AND OPPORTUNITIES
Further mergers and acquisitions, and brand extensions likely
Immunity for the longer-term
Personalisation and subscription services
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2016-2021
Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN AUSTRALIA
HEADLINES
PROSPECTS
Marketing the benefits of dietary supplements
Personalisation and subscription services.
Private label set to expand in fragmented competitive landscape
PROSPECTS AND OPPORTUNITIES
COVID-19 fast-tracks the use of technology
New products and the rise of "purpose-driven" businesses
Competition from functional foods
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Trend towards healthy, home-cooked meals hampers growth of meal replacement
Supplement nutrition drinks remains only positive performer in 2021
Herbalife retains overall leadership, while Abbott Australasia continues to gain significant ground in supplement nutrition drinks
PROSPECTS AND OPPORTUNITIES
Obesity rates in Australia expected to contribute to improving demand for OTC obesity over course of forecast period
Holistic approach to food to further reduce reliance on weight management
Supplement nutrition drinks to remain strongest performer
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN AUSTRALIA
HEADLINES
PROSPECTS
Stable demand for sports nutrition in 2021 as health-conscious Australians continue to follow fitness regimes
Changing regulations for some sports nutrition products
Musashi remains dynamic performer in highly fragmented competitive landscape
PROSPECTS AND OPPORTUNITIES
Positive performance for sports nutrition as Australians return to regular exercise as part of healthy lifestyles
Sports nutrition to increasingly push boundaries
Chemist Warehouse strengthens sports nutrition with INC Protein
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Solid performance for herbal/traditional products due to consumers' positive perception
Dynamic growth despite challenges posed by COVID-19
Strong presence of local brands in highly fragmented competitive landscape
PROSPECTS AND OPPORTUNITIES
Shifting demographics continue to have a profound impact on growth
Search for natural options by Australian parents
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN AUSTRALIA
HEADLINES
2021 DEVELOPMENTS
Limited growth for paediatric cough, cold and allergy remedies in 2021
COVID-19 has positive ripple effect on value growth for paediatric analgesics
Pharmacare Laboratories maintains convincing leadership
PROSPECTS AND OPPORTUNITIES
New product development in paediatric consumer health has potential to drive demand over forecast period
Stronger growth opportunities may be limited due to predicted stagnant birth rates
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
